Universal serologic screening for celiac disease among 12-year-olds was more costly and yielded no gains in long-term quality of life in relation with bone health compared with the standard selective screening, a study in the journal Clinical Gastroenterology and Hepatology showed. Researchers also said that universal serological screening can lead to negative outcomes from unneeded endoscopic evaluations of healthy people if screening is falsely positive.

Related Summaries